Tiaho F, Nerbonne J M
Department of Molecular Biology and Pharmacology, Box 8103, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO 63110, USA.
Pflugers Arch. 1996 Sep;432(5):821-30. doi: 10.1007/s004240050204.
Vasoactive intestinal peptide (VIP) is colocalized in parasympathetic nerve terminals in the heart and coreleased from these nerve terminals with the "classical" neurotransmitter acetylcholine (Ach). VIP also exerts a positive inotropic effect on the intact heart and enhances adenylyl cyclase activity in isolated heart membranes. Using the whole-cell patch-clamp technique, we show here that VIP enhances Ca2+ and Ba2+ currents (IBa) through voltage-dependent L-type Ca2+ channels in adult rat ventricular myocytes. Neither the kinetics nor the voltage-dependent properties of the currents are affected. The effect of VIP on IBa is dose dependent with a half-maximal concentration of approximately 0.4 microM. The onset of the effect of VIP and the recovery phase are slow, suggesting the involvement of an intracellular second messenger. The effect of VIP on IBa is antagonized by a peptide analog of the growth hormone releasing factor ([Ac-Tyr1, D-Phe2]-GRF) which belongs to the same peptide family as VIP. Although VIP and the beta-adrenergic receptor agonist isoproterenol (ISO) enhance IBa peak amplitudes to approximately the same extent, the effect of VIP is not seen on all cells. Only approximately 50% of the isolated myocytes respond to 5 microM VIP, whereas 95% of the cells respond to ISO. Similar results were obtained using the amphotericin B perforated-patch whole-cell-recording technique, suggesting that the variable response to VIP does not reflect the loss of a pivotal intracellular regulator. The gastrointestinal hormone secretin, a peptide structurally related to VIP, also potentiates IBa in adult rat ventricular myocytes, although secretin is substantially more potent than VIP (half-maximal concentration for secretin is about 0.7 nM). Taken together, these results suggest that the VIP- (and secretin-) induced potentiation of IBa in adult rat ventricular myocytes is mediated through a non-VIP-preferring class of VIP receptors.
血管活性肠肽(VIP)与心脏副交感神经末梢共定位,并与“经典”神经递质乙酰胆碱(Ach)从这些神经末梢共同释放。VIP对完整心脏也具有正性肌力作用,并增强离体心脏膜中的腺苷酸环化酶活性。利用全细胞膜片钳技术,我们在此表明,VIP可增强成年大鼠心室肌细胞中通过电压依赖性L型钙通道的Ca2+和Ba2+电流(IBa)。电流的动力学和电压依赖性特性均未受影响。VIP对IBa的作用呈剂量依赖性,半数最大浓度约为0.4 microM。VIP作用的起效和恢复阶段较慢,提示涉及细胞内第二信使。VIP对IBa的作用被生长激素释放因子的肽类似物([Ac-Tyr1, D-Phe2]-GRF)拮抗,该类似物与VIP属于同一肽家族。尽管VIP和β-肾上腺素能受体激动剂异丙肾上腺素(ISO)使IBa峰值幅度增加的程度大致相同,但并非所有细胞都能观察到VIP的作用。仅约50%的分离心肌细胞对5 microM VIP有反应,而95%的细胞对ISO有反应。使用两性霉素B穿孔膜片全细胞记录技术也获得了类似结果,提示对VIP的可变反应并不反映关键细胞内调节因子的丧失。胃肠激素促胰液素是一种结构上与VIP相关的肽,它也能增强成年大鼠心室肌细胞中的IBa,尽管促胰液素比VIP的效力强得多(促胰液素的半数最大浓度约为0.7 nM)。综上所述,这些结果表明,成年大鼠心室肌细胞中VIP(和促胰液素)诱导的IBa增强是通过一类非VIP特异性的VIP受体介导的。